Goldman Sachs Group Inc Oncolytics Biotech Inc Call Options Transaction History
Goldman Sachs Group Inc
- $596 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ONCY
# of Institutions
52Shares Held
1.37MCall Options Held
0Put Options Held
0-
International Assets Investment Management, LLC Orlando, FL207KShares$70,3460.01% of portfolio
-
Seeds Investor LLC New York, NY190KShares$64,5790.03% of portfolio
-
Royal Bank Of Canada Toronto, A667.1KShares$22,8170.0% of portfolio
-
Geode Capital Management, LLC Boston, MA66.9KShares$22,7590.0% of portfolio
-
Franklin Resources Inc San Mateo, CA63.3KShares$21,5130.0% of portfolio
About ONCOLYTICS BIOTECH INC
- Ticker ONCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 57,867,400
- Market Cap $19.7M
- Description
- Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...